Medications

FDA approves first liquid, nonstimulant ADHD treatment

The U.S. Food and Drug Administration has approved Tris Pharma's once-daily Onyda XR (clonidine hydrochloride) as the first liquid, nonstimulant treatment for attention-deficit/hyperactivity disorder (ADHD).

Attention deficit disorders

Study promotes digital help for adults with ADHD

Digital health experts at Flinders University are developing a mobile self-monitoring app model to assist adults with Attention-Deficit Hyperactivity Disorder (ADHD) take a more pro-active role in their "wellness journey."

Attention deficit disorders

Sweden orders review after 'explosion' of ADHD cases

Sweden is seeing "an explosion" of ADHD cases among children that has put it far above the global average, the government said Friday as it ordered a review to find out why.

page 5 from 40